Shots: 3BP to receive $12M up front, R&D milestones, an additional potential milestone with royalties on sales. Clovis to get rights to develop peptide-targeted radionuclide therapy (PTRT) and imaging agent […]readmore
Tags : 3B Pharmaceuticals